[General epidemiology of invasive fungal disease]

Javier Pemán1, Miguel Salavert

  • 1Servicio de Microbiología, Hospital Universitario y Politécnico La Fe, Valencia, España. peman jav@gva.es

Insights

Invasive fungal infections are rising in vulnerable patients. This study highlights the prevalence of Candida and Aspergillus species, noting geographical and clinical variations in causative agents.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Clinical Microbiology

Background:

  • Invasive mycoses pose significant health risks, particularly for immunocompromised and critically ill individuals.
  • Prevalence of fungal pathogens like Candida, Cryptococcus, Pneumocystis, and Aspergillus varies by region, patient status, and healthcare setting.
  • Emerging trends in fungal infections necessitate updated epidemiological data.

Purpose of the Study:

  • To analyze the distribution and trends of prevalent fungal pathogens causing invasive mycoses.
  • To compare the epidemiological patterns of Candida and Aspergillus infections in Spain with international data.
  • To identify shifts in the frequency of specific fungal species, including azole-resistant strains.

Main Methods:

  • Review of multicentre candidaemia surveys and epidemiological data on invasive mycoses.
  • Analysis of species distribution for Candida and Aspergillus based on geographical and clinical factors.
  • Monitoring of emerging fungal species and antifungal resistance patterns.

Main Results:

  • Candida albicans is the most common cause of candidaemia in Spain, followed by C. parapsilosis, C. glabrata, C. tropicalis, and C. krusei.
  • Aspergillus spp. are the leading filamentous fungi causing invasive mycoses, with A. fumigatus being most frequent.
  • Increasing isolation of Aspergillus flavus, A. nidulans, and A. terreus reported, influenced by geographic and treatment factors.

Conclusions:

  • Epidemiological profiles of invasive fungal infections show regional specificities, differing from international trends.
  • Shifts in the prevalence of Candida and Aspergillus species require continuous surveillance and adaptation of treatment strategies.
  • Emergence of less common Aspergillus species and azole resistance underscores the need for ongoing research and monitoring.

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...